Since the tech sector peaked earlier this year, the market showed resilience with some indexes rising while tech declined. However, in September, broad market indexes like the equal-weighted S&P 500 and IWM peaked and then declined, signaling challenges ahead. The outlook suggests rising interest rates, high energy prices, and increased debt supply will persist, with the Federal Reserve likely to continue rate hikes. Big-cap tech and rate-resistant sectors currently lead, but if tech falters further, the overall market may struggle unless other sectors improve significantly.
The September market narrative shift and its lessons for Apple come amid a challenging environment for tech stocks. For readers following the technology sector, here is Pluang's market snapshot as of Sep 28, 2026 21:51 WIB: out of 150 priced US tech stocks, only 15 rose while 133 fell. Notable movers include VNET down 7.68%, MNDY down 7.23%, and QCOM down 6.91%, with typical hold times ranging from 15 to 88 days.
Vertex Pharmaceuticals reported a 12% revenue increase to $3.33 billion in Q2, driven by its dominant cystic fibrosis treatments. UBS raised its price target from $585 to $615, reflecting confidence in Vertex's strong financials and growth potential....
Accenture's stock surged 37.6% recently, driven by rising demand for AI services and new AI-focused offerings. The company outpaced industry growth and secured 100 new clients for advanced AI projects in one quarter. An analyst raised the price targe...
SpaceX, trading near $148 per share with a market cap of about $1.95 trillion, is preparing for Starship's first orbital mission and the deployment of its first operational Starlink V3 satellites. This milestone is key for expanding Starlink's global...
Argus Research initiated coverage on 10x Genomics with a Buy rating and a $110 price target, suggesting a 28% upside from its current price of around $85. The stock shows strong momentum, trading well above its 50-day and 200-day moving averages. How...
Morgan Stanley reaffirmed an "Overweight" rating on Cullen/Frost Bankers, Inc., raising its price target to $201, signaling confidence in the bank's prospects. Major institutional investors like State Street Corp and BlackRock have increased or initi...
